ZhuZhou QianJin Pharmaceutical Co Ltd Financial Flexibility Index
ZhuZhou QianJin Pharmaceutical Co Ltd financial flexibility index. ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Financial Flexibility Index of 0.19x as of September 2025. Free cash flow of CN¥312.72 Million (operating CF CN¥288.83 Million minus capex CN¥23.89 Million) represents 0% of total liabilities (CN¥1.66 Billion). See ZhuZhou QianJin Pharmaceutical Co Ltd (600479) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Financial flexibility index of ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2025. Historical Financial Flexibility Index trend for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. Check ZhuZhou QianJin Pharmaceutical Co Ltd (600479) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
ZhuZhou QianJin Pharmaceutical Co Ltd Financial Flexibility Index by Year (2002–2025)
ZhuZhou QianJin Pharmaceutical Co Ltd financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for ZhuZhou QianJin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see ZhuZhou QianJin Pharmaceutical Co Ltd cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | CN¥604.41 Million | CN¥480.24 Million | CN¥1.61 Billion | ▲ +19.0% |
| 2024 | 0.31x | CN¥446.09 Million | CN¥398.77 Million | CN¥1.42 Billion | ▲ +6.6% |
| 2023 | 0.30x | CN¥487.10 Million | CN¥443.12 Million | CN¥1.65 Billion | ▼ -30.1% |
| 2022 | 0.42x | CN¥767.91 Million | CN¥733.47 Million | CN¥1.82 Billion | ▲ +3.1% |
| 2021 | 0.41x | CN¥557.45 Million | CN¥485.57 Million | CN¥1.36 Billion | ▼ -6.0% |
| 2020 | 0.44x | CN¥639.61 Million | CN¥542.37 Million | CN¥1.47 Billion | ▲ +163.0% |
| 2019 | 0.17x | CN¥196.11 Million | CN¥155.49 Million | CN¥1.18 Billion | ▼ -59.8% |
| 2018 | 0.41x | CN¥429.86 Million | CN¥383.47 Million | CN¥1.04 Billion | ▲ +26.5% |
| 2017 | 0.33x | CN¥340.77 Million | CN¥283.47 Million | CN¥1.05 Billion | ▲ +38.9% |
| 2016 | 0.23x | CN¥222.38 Million | CN¥140.88 Million | CN¥948.21 Million | ▲ +20.3% |
| 2015 | 0.20x | CN¥151.96 Million | CN¥67.48 Million | CN¥779.17 Million | ▼ -34.0% |
| 2014 | 0.30x | CN¥249.32 Million | CN¥183.34 Million | CN¥843.20 Million | ▼ -8.9% |
| 2013 | 0.32x | CN¥221.89 Million | CN¥137.63 Million | CN¥683.92 Million | ▼ -58.5% |
| 2012 | 0.78x | CN¥454.08 Million | CN¥197.82 Million | CN¥581.18 Million | ▲ +160.4% |
| 2011 | 0.30x | CN¥86.45 Million | CN¥22.58 Million | CN¥288.10 Million | ▼ -42.0% |
| 2010 | 0.52x | CN¥97.57 Million | CN¥39.13 Million | CN¥188.65 Million | ▼ -17.4% |
| 2009 | 0.63x | CN¥196.85 Million | CN¥73.54 Million | CN¥314.48 Million | ▼ -13.2% |
| 2008 | 0.72x | CN¥132.51 Million | CN¥37.20 Million | CN¥183.66 Million | ▲ +34.2% |
| 2007 | 0.54x | CN¥101.80 Million | CN¥79.26 Million | CN¥189.30 Million | ▼ -35.7% |
| 2006 | 0.84x | CN¥141.51 Million | CN¥120.12 Million | CN¥169.13 Million | ▲ +82.5% |
| 2005 | 0.46x | CN¥93.24 Million | CN¥76.50 Million | CN¥203.38 Million | ▼ -9.2% |
| 2004 | 0.51x | CN¥74.95 Million | CN¥18.45 Million | CN¥148.38 Million | ▲ +11.8% |
| 2003 | 0.45x | CN¥85.01 Million | CN¥50.96 Million | CN¥188.23 Million | ▲ +20.5% |
| 2002 | 0.37x | CN¥65.31 Million | CN¥6.07 Million | CN¥174.31 Million | — |